X-linked inhibitor of apoptosis (XIAP), which inhibits caspases, was reported to be suppressed in the lysates of FG-3019-treated murine pancreatic cancers and the effect was most pronounced in the FG-3019 + gemcitabine combination group [24]. The gene discussed is XIAP; the disease is familial pancreatic carcinoma.